top-banner

METHODS AND TECHNOLOGIES

Multiplex Ligation-Dependent Probe Amplification

MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION

The MLPA (Multiplex Ligation-dependent Probe Amplification) method for detecting dosage differences of up to 50 different nucleic acid fragments in a single reaction was first described in 2002 (Schouten et al., Nucl Acids Res 30:12e57). In this study, the copy number of 40 loci in the human genome was determined through simultaneous relative quantification. The amount of sequence-specific hybridized and ligated oligonucleotides is proportional to the copy number of the target sequence.

The amplification products are subsequently separated by size using capillary electrophoresis. Dose differences are identified by reductions or increases in heights and areas of the detected peaks.

To date, more than 300 different MLPA kits are commercially available for the detection of deletions/duplications of single exons within genes, gene regions, entire genes, chromosomal segments, and even whole chromosomes (e.g., from MRC-Holland).

Variants of the basic MLPA technique have also been developed:

RT-MLPA (reverse transcriptase MLPA): Used for mRNA profiling.

MS-MLPA (methylation-specific MLPA): Determines copy number and analyzes methylation patterns, enabling imprinting defect detection and tumor analysis.

WAYS TO PARTNER WITH US

TarCET IVD Kits

CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form

Learn more

Technology Transfer

Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing

Learn more

Genetic Testing Laboratory

Your partner for
all genetic tests

Learn more

Contact Us

Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.

Learn more

BLOG ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact …

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc…

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of …

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access…

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is…

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti…

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati…

Read more

OUR NETWORK